Skip to content

RVMD

Revolution Medicines, Inc.

Stock

$205.26+0.78 (+0.38%)Close Sep 30, 2026

Operating cash flow (TTM)−$1.2B

Operating cash flow

PeriodOperating cash flowYoY
2025−$898M—
2024−$557M—
2023−$351M—
2022−$224M—
2021−$147M—
2020−$100M—
2019−$50M—
2018$1.2M—